FDA Seeks Input on Drug Fee Spending at June Public Meeting
Published Date: 4/15/2026
Notice
Summary
The FDA is hosting a public meeting on June 23, 2026, to talk about how money from drug user fees is spent and how to make the process clearer and more efficient. This affects drug companies paying fees for prescription, biosimilar, and generic drugs. People can join in person or online and send their thoughts by July 23, 2026, helping shape future fee rules and transparency.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09767, Oscar Bobo: Final Debarment Order
Oscar Bobo is officially banned for 5 years from importing any drugs into the U.S. because he repeatedly brought in mislabeled medicines that don’t follow FDA rules. He didn’t respond to the FDA’s warning, so the ban started on May 15, 2026. If he wants to end the ban early, he can apply anytime, but must follow special rules to keep his info private.
2026-09533, Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information
The FDA wants your help to improve tests that spot kidney damage caused by medicines. They’re asking researchers, doctors, and companies to share data by July 13, 2026, so they can make these kidney safety markers better and faster. This could lead to safer drugs and smarter health checks, benefiting patients and the medical community alike.
2026-09508, Azodicarbonamide (ADA); Request for Information
The FDA is asking for info about azodicarbonamide (ADA), a chemical used in some foods and food packaging, to check if it’s still safe. Food makers, scientists, and anyone with data should share what they know by July 13, 2026. This review could lead to changes in how ADA is used, affecting food companies and possibly costs down the line.
2026-09543, Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting
The FDA wants your thoughts on how drug companies report problems after their products hit the market. This update affects drug makers and helps keep medicine safe by improving how side effects are tracked. You’ve got until July 13, 2026, to share your comments—no cost to join, just your voice!
2026-09544, Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.
The FDA is inviting the public to comment on the renewal of special approval for two cigarette products by 22nd Century Group Inc. These products claim to lower health risks compared to regular cigarettes. If renewed, the company can keep marketing them this way, with the comment period starting May 13, 2026.
2026-09507, Butylated Hydroxytoluene (BHT); Request for Information
The FDA wants to know more about how butylated hydroxytoluene (BHT), a chemical used in food and food packaging, is being used and if it’s still safe. They’re asking companies, scientists, and the public to share any info by July 13, 2026. This could lead to changes in rules that affect food makers and might impact what’s allowed in your snacks and packaging.
Previous / Next Documents
Previous: 2026-07247, Advisory Council on Alzheimer's Research, Care, and Services; Meeting
The Advisory Council on Alzheimer's is meeting on April 27, 2026, to share updates and new ideas to help people with Alzheimer's and their caregivers. They’ll talk about better long-term care, early diagnosis, and community support tools. This meeting affects patients, families, and care providers by shaping future services and support options.
Next: 2026-07249, Corpus Christi Liquefaction, LLC; Corpus Christi Liquefaction Stage IV, LLC; and Cheniere Marketing, LLC; Application for Long-Term Authorization To Export Liquefied Natural Gas to Non-Free Trade Agreement Nations
Corpus Christi Liquefaction, LLC and partners want to expand their Texas LNG terminal to export a huge amount of natural gas—about 1,200 billion cubic feet per year—to countries without free trade deals. This long-term plan could boost U.S. energy exports and impact global markets. Public comments and protests are open until June 15, 2026, so now’s the time to speak up!